Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

MERIN MARIE KINIKINI

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1326127895
CMS profile
10600904
Location
SALT LAKE CITY, UT

General Payments · PY2021–2025

$18,982.54

  • Reported across 85 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$3,285.20

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Fresenius Kabi USA, LLC $1,728.79 5
Takeda Pharmaceuticals U.S.A., Inc. $1,556.41 8

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,138.83 6
PY2022 $244.29 7
PY2023 $8,201.23 33
PY2024 $6,112.99 26
PY2025 $3,285.20 13

Payment records · PY2025 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2025 2021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Fresenius Kabi USA, LLC $69.79 03/22/2025 Food and Beverage Undisputed 06/30/2026 1250518994 CMS
Fresenius Kabi USA, LLC $14.00 04/17/2025 Travel and Lodging Undisputed 06/30/2026 1250518986 CMS
Fresenius Kabi USA, LLC $20.00 04/17/2025 Travel and Lodging Undisputed 06/30/2026 1250518990 CMS
Fresenius Kabi USA, LLC $125.00 04/17/2025 Food and Beverage Undisputed 06/30/2026 1250518997 CMS
Fresenius Kabi USA, LLC $1,500.00 04/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1250519001 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.45 10/02/2025 Food and Beverage Undisputed 06/30/2026 1223993664 CMS
Takeda Pharmaceuticals U.S.A., Inc. $125.00 11/07/2025 Food and Beverage Undisputed 06/30/2026 1224095539 CMS
Takeda Pharmaceuticals U.S.A., Inc. $192.66 11/07/2025 Travel and Lodging Undisputed 06/30/2026 1224101153 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3.65 11/08/2025 Food and Beverage Undisputed 06/30/2026 1223949097 CMS
Takeda Pharmaceuticals U.S.A., Inc. $50.00 11/08/2025 Food and Beverage Undisputed 06/30/2026 1224094021 CMS
Takeda Pharmaceuticals U.S.A., Inc. $70.00 11/08/2025 Food and Beverage Undisputed 06/30/2026 1224094203 CMS
Takeda Pharmaceuticals U.S.A., Inc. $75.00 11/08/2025 Food and Beverage Undisputed 06/30/2026 1224094251 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,022.65 11/08/2025 Travel and Lodging Undisputed 06/30/2026 1224101326 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.